Anthropic warns of ‘existential risks to humanity’ from AI; AstraZeneca makes $2bn cancer drug tie-up – business live
Source: The Guardian ·
Rolling coverage of the latest economic and financial newsPharmaceuticals news: AstraZeneca is investing $2bn in biopharmaceutical oncology company Summit Therapeutics, as part of a tie-up to jointly develop and test anti-cancer drugs.Announcing the deal, AstraZeneca says the two companies will collaborate on a series of studies testing their cancer treatments together.“A core pillar of our…
From the source
Good morning, and welcome to our rolling coverage of business, the financial markets and the world economy. Anthropic’s plan to float on the stock market has provided a sobering insight into the risks that AI poses, even as it attempts to pull off a massive share sale to the public. Reuters has taken a look at Anthropic’s IPO prospectus – the legal document that outlines a company’s financial details before it floats on the stock market – and found that it includes a warning that advanced AI could be a “catastrophic or existential risks to humanity.” And following a flurry of stories about AI models going rogue, Anthropic flags that its models could conceal information and exhibit behavior resembling blackmail, and resist efforts to shut them down. Such warnings appear across 80 pages (!) devoted to risk factors in the prospectus, almost a third of the document. Despite these warnings, Anthropic is aiming for one of the largest stock market flotations ever, which could value it at…